Limerick: Edwards Lifesciences to open new factory at National Technology Park
In the three years since establishing its first manufacturing facility in Ireland, Edwards Lifesciences has grown and employs 200 people in the Midwest.
The US-based life sciences company set up its first manufacturing base in Shannon in 2018 and has now completed construction of a new 190,000 square foot manufacturing facility in Castleroy National Technology Park in the exterior of the city of Limerick.
Recruitment for the new site is underway and plans to employ 650 people at the site when it is fully operational.
“Our plans in Limerick are to grow rapidly. We have hired 200 of our first 650 people and more are added every day, ”said Nathan Tenzer, general manager of the Edwards Lifesciences plant in Ireland.
“We have a variety of roles, from product assembly, inspection and warehouse operations to engineering, supply chain and finance roles to support the plant.
“New cutting-edge technologies will continue to settle in our brand new factory in Limerick and we look forward to making further growth announcements in the future. “
Edwards Lifesciences is a global leader in patient-centered medical innovations for structural heart disease, as well as critical care and surgical monitoring.
The company is headquartered in Irvine, California, and its European headquarters in Nyon, Switzerland.
“Although we have had a sales office in Dublin for some time, our manufacturing plants [in Ireland] are very new, ”Tenzer said.
“Edwards needed to expand their manufacturing facilities and really wanted to base their new investment in Europe, our second largest market.
“The Shannon facility was created from an existing structure in 2018, and the Limerick facility was purpose built with construction completed in March of this year. “
Both factories were involved in manufacturing delivery systems used to repair and replace damaged heart valves, Tenzer said.
“Once our validation and registrations are complete, products manufactured at our facilities in Limerick and Shannon will be delivered to patients around the world. “
For Edwards Lifesciences, manufacturing in the Midwest provided easy access to Europe and the opportunity to move forward with “vital expansion enabling global business continuity,” Tenzer said.
The decision of the American company to establish a base in Ireland was also influenced by a number of other factors.
“First and foremost is access to phenomenal people. Ireland is known to invest heavily in education, ”Tenzer said.
“He has a very solid base of people with medical device experience and it’s easy to work with companies. It is politically stable and has very reliable infrastructure.